Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
Bariatric surgery remains the most durable option for significant weight loss For individuals with higher starting weights or obesity-related health conditions, surgery typically results in greater and more sustained weight loss than medication alone
Our medical team reviews your health history before starting treatment
We address those root causes alongside the GLP-1 therapy so that results hold long term, not just while you are on the medication
In late 2025, Eli Lilly released topline data from the first successful Phase 3 trial of retatrutide , its investigational triple agonist peptide therapy
US$ 26.43
US$ 27.24
US$ 22.54
US$ 25.69
US$ 20.12
US$ 21.83
